Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 2005-2011, September 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eisen, H. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eisen, H. N.

Learning and Memory in the Immune Response1

Herman N. Eisen

Department of Microbiology, Washington University School of Medicine, Saint Louis, Missouri

Following 1 injection of rabbits with moderate amounts of some dinitrophenylated proteins, the 7 S antibodies formed initially have low average affinity for the 2,4-dinitrophenyl (DNP) group, and appear relatively homogeneous with respect to affinity. The anti-DNP molecules formed later appear more heterogeneous in binding activity and have higher average affinity for the DNP group. The rate of increase in affinity, and of heterogeneity in binding activity, is retarded by large doses of the immunogen (> 100 mg/animal). After the response to the 1st injection has subsided, a 2nd injection of the immunogen evokes a burst of synthesis of anti-DNP molecules which, within a few days, have the same binding properties as those formed many months after the initial injection. The results are interpreted in terms of selective stimulation or repression of diverse anti-DNP-producing cells, with the level of immunogen controlling the cell's activity or dormancy by interaction with hypothetical "sentinel" antibody molecules on the cell's surface. In keeping with this interpretation, in the secondary response elicited by an immunogen that resembles the initial immunogen (e.g., TNP-protein for the 2nd and DNP-protein for the 1st injection), the antibodies formed were much like those that would have been formed to a 2nd injection of the original immunogen.

1 Based on talks presented as the J. Howard Mueller Memorial Lecture at the Harvard Medical School, Boston, Mass., December 8, 1964, and as The Enrique Ecker Lecture at the Western Reserve University School of Medicine, May 1965. This work was supported in part by a USPHS research grant (AI-03231), and a training grant (5T1-A1-257), both from the National Institute for Allergy and Infectious Diseases, and by a contract with the Research and Development Command, Department of the Army, recommended by the Commission on Immunization of the Armed Forces Epidemiological Board (DA-49-193-MD-2330).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.